4//SEC Filing
Freitag Gregory Gene 4
Accession 0000805928-24-000075
CIK 0000805928other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:49 PM ET
Size
7.1 KB
Accession
0000805928-24-000075
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Freitag Gregory Gene
DirectorCFO
Transactions
- Exercise/Conversion
Common Stock
2024-06-04+11,904→ 283,498 total - Exercise/Conversion
Restricted Stock Units
2024-06-04−11,904→ 0 total→ Common Stock (11,904 underlying)
Footnotes (2)
- [F1]Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001492710
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:49 PM ET
- Size
- 7.1 KB